1. Date of the Annual General Meeting: 2026/05/28 2. Key Resolution 1, Profit Distribution or Loss Offsetting: Approved the 2025 profit distribution proposal. 3. Key Resolution 2, Articles of Incorporation Amendment: None. 4. Key Resolution 3, Business Report and Financial Statements: Approved the 2025 business report and financial statements. 5. Key Resolution 4, Election of Directors and Supervisors: None. 6. Key Resolution 5, Other Matters: Approved the proposal for a capital increase by capitalization of earnings (issuance of new shares). 7. Other Matters to be Noted: None.

FACT BOX

  • Source: PR Times
  • Category: Corporate Governance
  • Organizations: PharmaEssentia